The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st-century toxicity testing and next-generation risk assessment. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 963845 The content of the ONTOX LinkedIn page is the sole responsibility of the ONTOX project and does not necessarily reflect the opinion of the EU.
| Website | https://ontox-project.eu |
| Employees | 6 (0 on RocketReach) |
| Phone | +32 2 477 45 87 |
| Industry | Research Services |
| Keywords | Chemical Risk Assessment, Toxicity Testing, In Vitro Toxicology, Chemical Safety Assessment, Toxicology Research, Predictive Toxicology, Regulatory Toxicology, Safety Pharmacology, Risk Assessment Software, Cheminformatics, Environmental Toxicology, Drug Development |
| Competitors | Wiley, Celerion, Rules-Based Medicine a Q² Solutions Company, AIT Austrian Institute of Technology GmbH, Insilico Medicine, Chemaxon, Cyprotex, CureMetrix, Progenra, Inc., CRL design +24 more (view full list) |
Looking for a particular ONTOX employee's phone or email?
ONTOX Questions
ONTOX is based in Brussels, Brussels.
Related Companies
G2Crowd Trusted
300K+
Plugin Users
